금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
China warns of countermeasures over expanded US investment curbs on biotech
A Chinese official stated that it “firmly opposes” a US Treasury proposal to expand the scope and in...
Lula is re-elected Brazil’s president in knife-edge election
Victory of 80-year-old leftist over Flávio Bolsonaro is blow to Trump’s aim of greater US influence ...
MiMedx rises after Craig-Hallum raises price target on Sanara Deal
Mortgage rates rise slightly after two consecutive weeks of decrease
LTC Properties raised to Buy at Deutsche Bank on seniors' housing growth
Investors Are Missing Oracle’s AI Boom. Citi Says Buy.
Oracle stock is in a weird spot. Sales and earnings growth are exploding, but that hasn’t stopped shares from plummeting in recent months. Enough is enough for Citi analyst Tyler Radke: He put a “p ...
Enterprise software stocks rally as Salesforce CEO says time to stop SaaSpocalypse 'nonsense'
Is Kohl's Stock a Buy as Value Meets a Still-Fragile Sales Recovery?
Kohl's low valuation, higher earnings outlook and stronger liquidity support the buy case, but negative comparable sales and estimate cuts cloud the recovery.
Kohl's Stock Is Up 15.6% in 3 Months: Is the Rebound Sustainable?
Kohl's 15.6% three-month rally is backed by a Q2 earnings beat, merchandising gains and stronger liquidity, but falling comparable sales test the rebound.
KEEL Stock Jumps 56% in 6 Months: Here's What You Should Know
Keel's 56% six-month surge reflects its HPC/AI pivot, a 2.2-GW pipeline and progress at key data-center sites as tenant talks advance.
RHI Shares Rise 87.6% in Six Months: Here's What You Should Know
Robert Half's 87.6% six-month stock gain reflects its above-industry ROE, improving cash flow and steady shareholder returns.
3 Healthcare Stocks with Promising Prospects
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only risi ...
CytomX gains Fast Track status for colorectal cancer antibody-drug conjugate
Why Is Werner (WERN) Up 6.1% Since Last Earnings Report?
Werner (WERN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.